ExyCell’s pre-configured and pre-fabricated modules reduce the design and construction effort, thereby shortening time to market for new drugs and vaccines. The standardized approach reduces risk and ensures cost certainty.
The construction of the main building and cleanrooms based on ExyCell modules takes place in parallel rather than in sequence, accelerating the project schedule by up to 50%.
Any existing building, such as a warehouse, can be upgraded to a state-of-the-art biomanufacturing facility by integrating ExyCell modules.
* ATMP refers to Advanced Therapy Medicinal Products, also known as Medicinal Products for Cell and Gene Therapies
Exyte has successfully completed the construction of the first ExyCell® facility in China, the CliniMACS Cell Factory® of Miltenyi Biotec, a global provider of integrated solutions for Advanced Therapy Medical Products (ATMPs).
The patented ExyCell technology was developed by Exyte as an end-to-end, integrated facility solution with standardized and modularized elements. These pre-configured and pre-fabricated modules enable fast-track construction thereby shortening time-to-market for new therapeutics and vaccines. The ExyCell facility is installed on the fourth floor of the ATLATL building located in the Zhangjiang High-Tech Park, and Miltenyi Biotec is now transferring production technology from Germany to China with regular operations for ATMP production is expected by autumn 2021. The facility will soon be open to visitors by appointment.
If you would like to know how ExyCell can improve your business, do not hesitate to send an email to info.bls(at)exyte.net - we are happy to get in touch!
Univercells Technologies
Siemens